1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The protease inhibitor cystatin C downregulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes
(
- Contribution to journal › Article
- 2010
-
Mark
Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders.
(
- Contribution to journal › Article
- 2009
-
Mark
Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
(
- Contribution to journal › Article
- 2004
-
Mark
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
(
- Contribution to journal › Article
-
Mark
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease : Elevated oxidized low-density lipoprotein and the anti-inflammatory effect of artorvastatin
(
- Contribution to journal › Article
- 2002
-
Mark
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
(
- Contribution to journal › Article
- 2000
-
Mark
Pravastatin down-regulates inflammatory mediators in human monocytes in vitro
(
- Contribution to journal › Article